HomeProductsBioactive CompoundsEpigeneticsEpigenetic Reader DomainInobrodib
Chemical structure of CAS 2222941-37-7

Inobrodib

CAS No.2222941-37-7
MDL No.N/A
MFC30H32F2N4O3
MW534.60
InChI KeySKDNDJWEBPQKCS-RIQBOWGZSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2222941-37-7
Product NameInobrodib

Associated Conditions

neoplasm·prostate cancer
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies.

Cancer cell • Vol. 41, Issue 12 • 2023
PMID: 37995682DOI: 10.1016/j.ccell.2023.11.001

Design, synthesis and biological evaluation of (R)-5-methylpyrrolidin-2-ones as p300 bromodomain inhibitors with Anti-Tumor activities in multiple tumor lines.

Bioorganic chemistry • Vol. 124 • 2022
PMID: 35439627DOI: 10.1016/j.bioorg.2022.105803

Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer.

Journal of medicinal chemistry • Vol. 65, Issue 1 • 2022
PMID: 34962793DOI: 10.1021/acs.jmedchem.1c01864

Targeting the p300/CBP Axis in Lethal Prostate Cancer.

Cancer discovery • Vol. 11, Issue 5 • 2021
PMID: 33431496PMC: PMC8102310DOI: 10.1158/2159-8290.CD-20-0751

Documentation

Similar Products